What is the methyrapon?

Metarapon is a drug prescribed to evaluate the functioning of the pituitary. This gland is responsible for the lesson of the adrenal gland for the production of cortisol, chemicals. Laboratory tests are performed after the patient has been taking medication so that the doctor can determine whether the correct amount of cortisol is produced. Metyrapon can also be used to treat Cushing's syndrome, a condition in which the body produces too much cortisol.

This medicine is used orally or by mouth with food or milk. The patient may be prescribed one or two doses that must be performed at the exact times specified by the physician. The next day he must see his doctor to have blood and urine samples. These samples are sent to the laboratory for analysis. Sometimes the patient can also be instructed to collect urine for the day before taking the medicine, as well as on the day it gives doses. Consistent by its body weight. The adult will usually be prescribed 2,000 to 3,000 milligrams (mg) as the only dose of the day before the tests. When a doctor orders the patient to make this dosage dHe was usually prescribed 750 mg to be collected every four hours, a total of six doses.

There may be some side effects that should be reported to the prescribed physician if they become serious. Patients may have nausea, headaches and drowsiness. Dizziness, dizziness, lightness and increased sweating may also occur. The loss of appetite, vomiting and stomach pain was also reported. When methapone is used for a long time to treat Cushing syndrome, it can also cause excessive hair growth, loss of hair trains and worsening acne.

More serious side effects require immediate care of the doctor. Patients rarely reported irregular heart rhythm with long -term use of Myscutapone, as well as skin rash, rapid weight gain and fever. The sore throat, unusual fatigue and swelling of the lower legs or legs were also reported. Muscle cramps and unusual blue may occurIny and women can rarely experience an enlarged clitoris.

Before using methyrapone for diagnostic purposes or for the treatment of Cushing syndrome, patients must publish their other health conditions, medicines and supplements. It can be contraindicated for use by those who have porphyria, thyroid disease and diabetes. Heart or liver disease, breast cancer and hypoglycaemia may also prevent the patient from using this drug. Metyrapon can interact with other drugs, including estrogens, acetaminophene and hydantoin.